Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 21, 2018; 24(43): 4939-4949
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4939
Figure 1
Figure 1 Study design, exclusion criteria, and the study cohort. OLT: orthotopic liver transplantation; CMV: Cytomegalovirus.
Figure 2
Figure 2 Kaplan-Meier plots of patient (A) and graft (B) survival in the total population, and graft survival in the study cohort (C).
Figure 3
Figure 3 Kaplan-Meier plots of recurrent primary sclerosing cholangitis-free survival in patients with pre-orthotopic liver transplantation inflammatory bowel disease (blue line) and de novo inflammatory bowel disease (red line).
Figure 4
Figure 4 Distribution of time to recurrent primary sclerosing cholangitis in patients with cyclosporine immunosuppression (red line) vs tacrolimus immunosuppression (blue line).